Corvex Inc Dossier
Qualitative Analysis
Business overview
Movano Inc. (doing business as Movano Health) underwent a profound corporate transformation in March 2026. Historically focused on developing medical-grade consumer health wearables, such as the FDA-cleared Evie Ring and EvieMED Ring, the company completed an all-stock merger with Corvex Legacy Holdings, Inc. on March 19, 2026. Following the merger, the combined entity was renamed Corvex, Inc. (effective March 23, 2026) and shifted its primary business focus to GPU-accelerated cloud computing infrastructure for AI workloads. The company now provides graphics processing unit (GPU) accelerated compute, confidential computing, and inference services purpose-built to protect and perform. While it continues to market its legacy medical device operations, its primary growth engine is now its Amplified AI Cloud platform.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Following the merger with Corvex Legacy Holdings, the company has shifted its primary business focus to GPU-accelerated infrastructure for AI workloads, operating high-density NVIDIA GPU clusters in a Tier III-designed data center.
Expected impact: Reposition the company as an engineering-led AI infrastructure provider, targeting high-margin model training and inference contracts.
Developing and deploying the 'Token Factory' platform, which represents the second layer of the company's AI strategy, focused on delivering scalable AI inference capabilities.
Expected impact: Deliver reliable, autoscaling, cost-efficient, and secure AI inference across environments for enterprise and federal customers.
Exploring strategic alternatives, including a potential sale or licensing agreement, for the legacy healthcare wearable assets (EvieMED Ring and proprietary RF technology).
Expected impact: Eliminate legacy cash burn and generate non-dilutive capital to support the core AI business.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To transform the company into an AI cloud computing provider specializing in GPU-accelerated infrastructure, shifting away from the capital-constrained legacy healthcare wearables business.
Financial impact: Added $518.3 million of goodwill and $15.4 million of intangible assets. Pro forma Q1 2026 revenue was $3.65 million, almost entirely generated by the AI platform, compared to reported revenue of $510,000.
Strategic Partnerships
High. Provides access to high-density GPU clusters (including H200 and HGX B200 systems) to support secure, high-throughput AI model training and inference.
Terms: Not explicitly disclosed, but involves long-term deployment and reserved-capacity contracts.
Medium. Represents a major long-term GPU lease agreement deploying a dedicated cluster of NVIDIA H200 GPUs.
Terms: Not explicitly disclosed, but drove a significant increase in deferred revenue.